article thumbnail

Addressing Generic Drug Market Challenges: Strategies for Stability and Affordability

Drug Patent Watch

The generic drug market in the United States faces significant challenges, including price volatility, supply chain disruptions, and strategies employed by brand-name manufacturers to delay market entry. To address these issues, several market-based proposals and regulatory reforms have been suggested.

article thumbnail

When a New Drug Fails at Launch: Who’s Most to Blame?

World of DTC Marketing

Bringing a new drug to market is a high-stakes game. The Brand Team: Missed the Market Reality At the center of many failed launches is a brand team that built a strategy on assumptions rather than evidence. Market Access: Payer Preparedness Was Lacking Even the best drugs can’t succeed without coverage. It’s a process.

Drugs 201
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why Your Medical Affairs Senior Leaders Need Commercial Launch Experience

World of DTC Marketing

The walls between departments—Medical Affairs, Marketing, Regulatory, Legal—are supposed to protect scientific integrity and patient safety. They Understand the Realities of the Market, Not Just the Molecule Scientific rigor is critical. Pharma is a complicated business. But too often, these walls turn into silos. Messaging shifts.

Marketing 244
article thumbnail

Pharma Research Trends: Leveraging Innovation for Smarter Marketing Strategies

Pharma Marketing Network

Just as a chef relies on quality ingredients for the perfect dish, marketers depend on cutting-edge research to craft campaigns that resonate with their audience. The Connection Between Pharma Research and Marketing Effective marketing starts with understanding your audience.

article thumbnail

Why Biosimilars Struggle Despite FDA Approval

World of DTC Marketing

Marketing Muscle Still Favors Brands Branded biologic manufacturers invest heavily in professional marketing and direct-to-consumer outreach. Without a strong marketing engine, biosimilars are often invisible to both doctors and patients. The result? multiple Humira biosimilars).

article thumbnail

The Future of Generic Drug Development for Emerging Markets: Opportunities and Challenges

Drug Patent Watch

The Future of Generic Drug Development: Opportunities and Challenges for Emerging Markets As the global healthcare landscape continues to evolve, emerging markets are playing an increasingly important role in shaping the future of generic drug development. Share your thoughts in the comments below!

article thumbnail

AI-Driven Brain Mapping Software Secures FDA Approval for Market Launch

Scienmag

Huang Professor of Neurological Surgery at WashU Medicine and co-founder of Sora Neuroscience, the company bringing Cirrus to market, emphasized the monumental implications this software holds for clinical imaging and brain mapping. Dr. Eric Leuthardt, who serves as the Shi H.